Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma
Author:
Affiliation:
1. Department of Hematology; Ankara University Medical School; Ankara Turkey
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/jca.21591/fullpdf
Reference133 articles.
1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais Du Myelome;Attal;N Engl J Med.,1996
2. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma;Child;N Engl J Med.,2003
3. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe;Fermand;J Clin Oncol.,2005
4. High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials;Koreth;Biol Blood Marrow Transplant.,2007
5. Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial;Palumbo;Blood.,2004
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma;Cancers;2023-01-09
2. Retracted: “Factors Affecting Time to Engraftment During Autologous Stem Cell Transplantation in Patients With Multiple Myeloma”;Plasmatology;2023-01
3. Pre-mobilization platelet count predicts stem cell yield during mobilization in patients with multiple myeloma;Cancer Pathogenesis and Therapy;2023-01
4. Long‐term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patients;Hematological Oncology;2022-08-06
5. Cyclophosphamide plus etoposide is a safe and effective mobilization regimen in patients with multiple myeloma;Transfusion and Apheresis Science;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3